JRCT ID: jRCTs052210081
Registered date:09/09/2021
Multi Point Pacing and Continuous Atrioventricular Conduction OPtimization of Cardiac Resynchronization Therapy: PPAP-CRT
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Heart failure(HF) patients who are indicated for CRT-D device |
Date of first enrollment | 09/09/2021 |
Target sample size | 50 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Both MultiPole Pacing feature and CRT AutoAdapt feature ON |
Outcome(s)
Primary Outcome | CRT responder rate at 6 months after CRT-D implantation |
---|---|
Secondary Outcome | 1. Responder rate in 24 months 2. Change in cardiac function (LVEF, LVESV, LVEDV) by myocardial perfusion scintigraphy 3. Change in echocardiogram (LVEF, LVESV, LVEDV) 4. Survival rate and non-incidence rate of cardiovascular event 5. Change in NYHA Class 6. Change in QRS width on EKG 7. Change in serum brain natriuretic peptide(BNP) 8. Clinical composite score 9. Change in QOL questionnaire 10. New onset of atrial fibrillation |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | 1. A patient who has never received CRT 2. A patient who is eligible for CRT according to the guideline of The Japanese Circulation Society(JCS) and scheduled for implantation of CRT-D 3. A patient with a fixed residence who can follow the scheduled follow-up 4. A patient who has signed and dated the informed consent |
Exclude criteria | 1. A patient who is suffering from AV block (excluding atrial conduction time 250 ms or more) 2. A patient who is suffering from chronic atrial fibrillation 3. A patient who underwent tricuspid valve surgery or has tricuspid cardiac surgery planned 4. A patients who has a life expectancy of less than 2 years with a non-cardiac cause 5. A patient who is pregnant, breastfeeding or may become pregnant 6. A patient who is less than 20 years of age at the time of consent 7. A patient who is already included or will enroll in another interventional study during this study 8. A patient who is judged by the Principal Investigator (PI) or the Sub-Investigator (SI) as ineligible for participation in this study due to another reason |
Related Information
Primary Sponsor | Kusano Kengo |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | BIOTRONIK JAPAN.INC. |
Secondary ID(s) |
Contact
Public contact | |
Name | Maki Yurugi |
Address | 6-1 Kishibe-Shimmachi Suita-city Osaka, Japan Osaka Japan 564-8565 |
Telephone | +81-6-6170-1070 |
yurugi.maki@ncvc.go.jp | |
Affiliation | National Cerebral and Cardiovascular Center |
Scientific contact | |
Name | Kengo Kusano |
Address | 6-1 Kishibe-Shimmachi Suita-city Osaka, Japan Osaka Japan 564-8565 |
Telephone | +81-6-6170-1070 |
kusanokengo@ncvc.go.jp | |
Affiliation | National Cerebral and Cardiovascular Center |